The aim of the present study was to compare immunohistochemical profiles (ER, PR, HER2, and Ki67) between the primary tumor and synchronous axillary lymph node metastasis and investigate the subsequent effects on neoadjuvant therapy response. This evidence concerns the gene MKI67 and metastatic malignant neoplasm in the lymph nodes.